Literature DB >> 18590725

Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.

Kae-Woei Liang1, Sui-Chu Yin, Chih-Tai Ting, Shing-Jong Lin, Chi-Mei Hsueh, Chiu-Yuan Chen, Shih-Lan Hsu.   

Abstract

Platelet-derived growth factor (PDGF) is released from vascular smooth muscle cells (VSMCs), endothelial cells, or macrophages after percutaneous coronary intervention and is related with neointimal proliferation and restenosis. Berberine is a well-known component of the Chinese herb medicine Huanglian (Coptis chinensis), and is capable of inhibiting growth and endogenous PDGF synthesis in VSMCs after in vitro mechanical injury. We analyzed the effects of berberine on VSMC growth, migration, and signaling events after exogenous PDGF stimulation in vitro in order to mimic a post-angioplasty PDGF shedding condition. Pretreatment of VSMCs with berberine inhibited PDGF-induced proliferation. Berberine significantly suppressed PDGF-stimulated Cyclin D1/D3 and Cyclin-dependent kinase (Cdk) gene expression. Moreover, berberine increased the activity of AMP-activated protein kinase (AMPK), which led to phosphorylation activation of p53 and increased protein levels of the Cdk inhibitor p21(Cip1). Compound C, an AMPK inhibitor, partly but significantly attenuated berberine-elicited growth inhibition. In addition, stimulation of VSMCs with PDGF led to a transient increase in GTP-bound, active form of Ras, Cdc42 and Rac1, as well as VSMC migration. However, pretreatment with berberine significantly inhibited PDGF-induced Ras, Cdc42 and Rac1 activation and cell migration. Co-treatment with farnesyl pyrophosphate and geranylgeranyl pyrophosphate drastically reversed berberine-mediated anti-proliferative and migratory effects in VSMCs. Based on these findings, we conclude that berberine inhibited PDGF-induced VSMC growth via activation of AMPK/p53/p21(Cip1) signaling while inactivating Ras/Rac1/Cyclin D/Cdks and suppressing PDGF-stimulated migration via inhibition of Rac1 and Cdc42. These observations offer a molecular explanation for the anti-proliferative and anti-migratory properties of berberine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590725     DOI: 10.1016/j.ejphar.2008.06.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  31 in total

1.  Nondestructive prediction of oren extract powder, a herbal medicine, in suppositories by chemometric near-infrared spectroscopy.

Authors:  Ryutaro Teraoka; Hiroyuki Abe; Tadaaki Sugama; Kiyomi Ito; Masaki Aburada; Makoto Otsuka
Journal:  J Nat Med       Date:  2011-10-18       Impact factor: 2.343

Review 2.  Advance of studies on anti-atherosclerosis mechanism of berberine.

Authors:  Min Wu; Jie Wang; Long-tao Liu
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

3.  Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies.

Authors:  Xiaoying Huang; Rong Fan; Yuanyuan Lu; Chang Yu; Xiaomei Xu; Xie Zhang; Panpan Liu; Shuangquan Yan; Chun Chen; Liangxing Wang
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

4.  Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation.

Authors:  Sung Hwan Ki; Jung-Woon Lee; Sung Chul Lim; Tran Thi Hien; Ji Hye Im; Won Keun Oh; Moo Yeol Lee; Young Hyun Ji; Yoon Gyoon Kim; Keon Wook Kang
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells.

Authors:  Junyu Ning; Gang Xi; David R Clemmons
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

6.  AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.

Authors:  Junyu Ning; David R Clemmons
Journal:  Mol Endocrinol       Date:  2010-04-02

7.  Dose-dependent beneficial and harmful effects of berberine on mouse oocyte maturation and fertilization and fetal development.

Authors:  Chien-Hsun Huang; Fu-Ting Wang; Wen-Hsiung Chan
Journal:  Toxicol Res (Camb)       Date:  2020-07-01       Impact factor: 3.524

8.  Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway.

Authors:  Andrew Remppis; Florian Bea; Henry Johannes Greten; Annette Buttler; Hongjie Wang; Qianxing Zhou; Michael R Preusch; Ronny Enk; Robert Ehehalt; Hugo Katus; Erwin Blessing
Journal:  Mediators Inflamm       Date:  2010-06-21       Impact factor: 4.711

9.  Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of AMP-activated protein kinase-α2 in vivo.

Authors:  Bin Liang; Shuangxi Wang; Qilong Wang; Wencheng Zhang; Benoit Viollet; Yi Zhu; Ming-Hui Zou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 10.  AMP-activated protein kinase: a stress-responsive kinase with implications for cardiovascular disease.

Authors:  Chunying Li; John F Keaney
Journal:  Curr Opin Pharmacol       Date:  2010-01-08       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.